No Data
No Data
Analysts' Top Healthcare Picks: Inozyme Pharma (INZY), Glaukos (GKOS)
Market Participants Recognise Glaukos Corporation's (NYSE:GKOS) Revenues
Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?
Glaukos Price Target Raised to $141.00/Share From $125.00 by Truist Securities
Glaukos Is Maintained at Buy by Truist Securities
No Data